NO942143D0 - Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av mediakmanter for forhindring av emesis og seksuell dysfunksjon - Google Patents

Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av mediakmanter for forhindring av emesis og seksuell dysfunksjon

Info

Publication number
NO942143D0
NO942143D0 NO942143A NO942143A NO942143D0 NO 942143 D0 NO942143 D0 NO 942143D0 NO 942143 A NO942143 A NO 942143A NO 942143 A NO942143 A NO 942143A NO 942143 D0 NO942143 D0 NO 942143D0
Authority
NO
Norway
Prior art keywords
tetrahydrobenz
emesis
carboxamides
indole
prevention
Prior art date
Application number
NO942143A
Other languages
English (en)
Other versions
NO321500B1 (no
NO942143L (no
Inventor
Mark Mortensen Foreman
J David Leander
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO942143D0 publication Critical patent/NO942143D0/no
Publication of NO942143L publication Critical patent/NO942143L/no
Publication of NO321500B1 publication Critical patent/NO321500B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19942143A 1993-06-10 1994-06-09 Anvendelse av et tetrahydrobenz[cd]indol-6-karboksamid for fremstilling av et medikament for behandling av seksuell dysfunksjon NO321500B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7519893A 1993-06-10 1993-06-10

Publications (3)

Publication Number Publication Date
NO942143D0 true NO942143D0 (no) 1994-06-09
NO942143L NO942143L (no) 1994-12-12
NO321500B1 NO321500B1 (no) 2006-05-15

Family

ID=22124191

Family Applications (4)

Application Number Title Priority Date Filing Date
NO19942143A NO321500B1 (no) 1993-06-10 1994-06-09 Anvendelse av et tetrahydrobenz[cd]indol-6-karboksamid for fremstilling av et medikament for behandling av seksuell dysfunksjon
NO991551A NO991551D0 (no) 1993-06-10 1999-03-30 Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av medikamenter for forebyggelse av emesis og behandling av seksuell dysfunksjon
NO993461A NO308693B1 (no) 1993-06-10 1999-07-14 Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider for fremstilling av medikamenter for forebyggelse av emesis
NO20015806A NO20015806D0 (no) 1993-06-10 2001-11-28 Farmasöytisk preparat inneholdende et tetrahydrobenz[c,d]indol-6-karboksamid og anvendelse derav

Family Applications After (3)

Application Number Title Priority Date Filing Date
NO991551A NO991551D0 (no) 1993-06-10 1999-03-30 Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av medikamenter for forebyggelse av emesis og behandling av seksuell dysfunksjon
NO993461A NO308693B1 (no) 1993-06-10 1999-07-14 Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider for fremstilling av medikamenter for forebyggelse av emesis
NO20015806A NO20015806D0 (no) 1993-06-10 2001-11-28 Farmasöytisk preparat inneholdende et tetrahydrobenz[c,d]indol-6-karboksamid og anvendelse derav

Country Status (17)

Country Link
US (1) US5703112A (no)
EP (2) EP1166783A3 (no)
JP (1) JPH0748254A (no)
KR (2) KR100367792B1 (no)
CN (2) CN1072932C (no)
AU (1) AU677317B2 (no)
CA (1) CA2125088A1 (no)
CZ (2) CZ285762B6 (no)
HK (1) HK1043322B (no)
HU (1) HUT71464A (no)
IL (1) IL109872A (no)
NO (4) NO321500B1 (no)
NZ (2) NZ260667A (no)
RU (1) RU2154476C2 (no)
TW (1) TW258660B (no)
UA (2) UA29415C2 (no)
ZA (1) ZA943862B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1173167A4 (en) 1999-04-30 2004-07-14 Lilly Icos Llc TREATMENT OF FEMALE SEXUAL STIMULATION DISORDERS
GB0106446D0 (en) * 2001-03-15 2001-05-02 Vernalis Res Ltd Chemical compounds
EP1890684B1 (en) 2005-06-08 2013-08-14 SK Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
EP1893291B1 (en) * 2005-06-22 2010-03-03 SK Holdings Co., Ltd. Treatment of sexual dysfunction
KR102173587B1 (ko) 2009-06-22 2020-11-04 에스케이바이오팜 주식회사 피로의 치료 또는 예방 방법
KR101783633B1 (ko) 2009-11-06 2017-10-10 에스케이바이오팜 주식회사 섬유근육통 증후군의 치료 방법
US8895609B2 (en) 2009-11-06 2014-11-25 Sk Biopharmaceuticals Co., Ltd. Methods for treating attention-deficit/hyperactivity disorder
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
SG11201507121RA (en) 2013-03-13 2015-10-29 Aerial Biopharma Llc Treatment of cataplexy
PT3021838T (pt) 2013-07-18 2020-09-01 Sk Biopharmaceuticals Co Ltd Tratamento para a obesidade
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
AU2018278332B2 (en) 2017-06-02 2022-05-19 Jazz Pharmaceuticals Ireland Limited Methods and compositions for treating excessive sleepiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
US4943428A (en) * 1987-07-10 1990-07-24 Wright State University Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
WO1991000856A2 (en) * 1989-07-13 1991-01-24 The Upjohn Company (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
WO1991013872A1 (en) * 1990-03-15 1991-09-19 The Upjohn Company Therapeutically useful heterocyclic indole compounds
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof

Also Published As

Publication number Publication date
KR100367791B1 (ko) 2003-02-14
CZ285829B6 (cs) 1999-11-17
CN1342457A (zh) 2002-04-03
KR950000146A (ko) 1995-01-03
HK1043322A1 (en) 2002-09-13
KR100367792B1 (ko) 2003-02-19
UA37311C2 (uk) 2001-05-15
NO993461D0 (no) 1999-07-14
NO20015806L (no) 1994-12-12
IL109872A0 (en) 1994-10-07
NO321500B1 (no) 2006-05-15
NO20015806D0 (no) 2001-11-28
ZA943862B (en) 1995-12-04
EP0633023A2 (en) 1995-01-11
CN1170536C (zh) 2004-10-13
AU6460794A (en) 1994-12-15
NO991551D0 (no) 1999-03-30
HU9401730D0 (en) 1994-09-28
NO942143L (no) 1994-12-12
NZ260667A (en) 1997-05-26
UA29415C2 (uk) 2000-11-15
CZ285762B6 (cs) 1999-11-17
NO993461L (no) 1994-12-12
JPH0748254A (ja) 1995-02-21
EP1166783A3 (en) 2002-01-09
CN1100634A (zh) 1995-03-29
NZ314570A (en) 2000-11-24
IL109872A (en) 2000-12-06
HK1043322B (zh) 2005-06-03
AU677317B2 (en) 1997-04-17
HUT71464A (en) 1995-11-28
RU2154476C2 (ru) 2000-08-20
RU94020717A (ru) 1996-08-27
US5703112A (en) 1997-12-30
CN1072932C (zh) 2001-10-17
TW258660B (no) 1995-10-01
NO308693B1 (no) 2000-10-16
CZ135494A3 (en) 1994-12-15
EP0633023A3 (en) 1995-03-29
NO991551L (no) 1994-12-12
EP1166783A2 (en) 2002-01-02
CA2125088A1 (en) 1994-12-11

Similar Documents

Publication Publication Date Title
PL313973A1 (en) 1 n-alkyl-n-arylopyrimidin amines and their derivatives
AU5590596A (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
NO962179L (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
NO933835D0 (no) Dobbeltvegget komposittroer og sammenkoplingsenhet samt fremgangsmaate for fremstilling av dette
NO942143L (no) Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av mediakmanter for forhindring av emesis og seksuell dysfunksjon
AU6803594A (en) Phenylcyclopropane compounds and their use as camp and tnf inhibitors
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU3745895A (en) Use of gaba antagonists in the treatment of emesis
NO933477L (no) 6-heterosyklisk-4-amino-1,3,4,5-tetrahydrobenz(cd)indoler for behandling av reisesyke og oppkast
NO961226D0 (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
HU9502863D0 (en) 7-azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
EP0688225A4 (en) METHODS AND COMPOSITIONS FOR INHIBITING SUPPLEMENT ACTIVATION
AU4505996A (en) 7-vinylidene cephalosporins and methods of using the same
EP0615148A3 (de) Verfahren und Vorrichtung zur Polarisation von Licht.
AU6218594A (en) Silicon carbide bodies and methods of making the same
GB9315281D0 (en) Method and composition for facilitating the removal of soil contaminants from solid surfaces
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders
AU2460595A (en) Methods based on the role of neurotrophin 3 in female reproduction
EP0714659A3 (en) Indole derivatives in the treatment of emesis
EP0584375A4 (en) Transposable element originating in bacterium of the genus brevibacterium
AU1789192A (en) Seating for stadia and the like
AU6709796A (en) Immunologically tolerant vertebrate and use of the same
NO176628C (no) Fremgangsmåte og anordning til å motvirke dannelse av spenninger i rörledninger og lignende
ZA935409B (en) Inorganic perbromide compositions and methods of use thereof